This brand name is authorized in France, Malta, Tunisia
The drug OFLOCET contains one active pharmaceutical ingredient (API):
|
1
Ofloxacin
UNII A4P49JAZ9H - OFLOXACIN
|
|
Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S02AA16 | S Sensory organs → S02 Otologicals → S02A Antiinfectives → S02AA Antiinfectives | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 66484819, 68399214 |
| Country: MT | Medicines Authority | Identifier(s): MA1359/01801 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9263191, 9263192 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
